Geode Capital Management
VERA icon

Geode Capital Management’s Vera Therapeutics VERA Stock Holding History

Geode Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.6M Buy
1,692,442
+122,365
+8% +$4.56M ﹤0.01% 1422
2026
Q1 		$63.2M Buy
1,570,077
+125,152
+9% +$5.39M ﹤0.01% 1363
2025
Q4 		$73.2M Buy
1,444,925
+123,350
+9% +$4.38M ﹤0.01% 1268
2025
Q3 		$38.4M Buy
1,321,575
+26,617
+2% +$616K ﹤0.01% 1653
2025
Q2 		$30.5M Buy
1,294,958
+92,149
+8% +$2.07M ﹤0.01% 1720
2025
Q1 		$28.9M Buy
1,202,809
+49,484
+4% +$1.59M ﹤0.01% 1691
2024
Q4 		$48.8M Buy
1,153,325
+148,660
+15% +$6.58M ﹤0.01% 1452
2024
Q3 		$44.4M Buy
1,004,665
+20,223
+2% +$767K ﹤0.01% 1496
2024
Q2 		$35.6M Buy
984,442
+23,133
+2% +$918K ﹤0.01% 1589
2024
Q1 		$41.5M Buy
961,309
+178,593
+23% +$6.36M ﹤0.01% 1487
2023
Q4 		$12M Buy
782,716
+44,149
+6% +$561K ﹤0.01% 2232
2023
Q3 		$10.1M Buy
738,567
+87,875
+14% +$1.51M ﹤0.01% 2261
2023
Q2 		$10.4M Buy
650,692
+170,647
+36% +$1.54M ﹤0.01% 2262
2023
Q1 		$3.73M Buy
480,045
+222,979
+87% +$1.72M ﹤0.01% 2764
2022
Q4 		$4.97M Buy
257,066
+17,266
+7% +$313K ﹤0.01% 2671
2022
Q3 		$5.11M Buy
239,800
+35,212
+17% +$659K ﹤0.01% 2666
2022
Q2 		$2.78M Buy
204,588
+2,041
+1% +$35.6K ﹤0.01% 2999
2022
Q1 		$4.76M Buy
202,547
+80,965
+67% +$1.74M ﹤0.01% 2823
2021
Q4 		$3.25M Buy
121,582
+49,974
+70% +$1.11M ﹤0.01% 3130
2021
Q3 		$1.24M Buy
71,608
+55,532
+345% +$993K ﹤0.01% 3571
2021
Q2 		$213K Buy
+16,076
New +$250K ﹤0.01% 4320

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management's VERA Position: Q2 2026 in Review

Geode Capital Management increased its Vera Therapeutics (VERA) stake by 7.8% in Q2 2026, buying an estimated $4.56M and bringing the position to 1,692,442 shares worth $72.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

Geode Capital Management first reported a position in VERA in Q2 2021 and has held it in 21 quarters since. The position peaked at $73.2M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Geode Capital Management held 1,692,442 shares of Vera Therapeutics worth $72.6M as of Q2 2026.
  • Geode Capital Management bought 122,365 Vera Therapeutics shares in Q2 2026, an estimated $4.56M.
  • Vera Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1422 holding.
  • Geode Capital Management first reported a position in Vera Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Vera Therapeutics position peaked at $73.2M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.